Global News
- All
- AI
- Markets
- Macroeconomics
What a fantastic six months it’s been for Guardant Health. Shares of the company have skyrocketed 46.9%, hitting $86.90. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
Energy Transfer and Enterprise Products Partners are two great stocks to own over the long haul.
For the time being, Red Cat is still selling its drones near cost. When will that change?
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms
A string of giants such as BlackRock, Morgan Stanley, and Blackstone have been the latest financial firms to impose redemption limits on private debt funds as investor anxiety builds.
Volatility in the stock market often leads to great long-term opportunities for investors.
Stocks under $10 pique our interest because they have room to grow (as well as the most affordable option contract premiums). That doesn’t mean they’re bargains though, and we urge investors to be careful as many have risky business models.
Everybody loves a good deal, but sometimes the price can be too much of a discount. That’s the dilemma facing SOFI stock.
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some may still have unproven business models, leaving them v
Micron did everything right in Q2. Investors sold it anyway.
Nebius’ $27 billion Meta deal highlights its growing role in AI infrastructure, but investors must weigh whether NBIS stock represents a high-growth opportunity or a capital-intensive bet with meaningful execution risks.
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorati
These stocks are down by more than half since last fall and appear oversold.
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of the